A model-based method for the prediction of whole-body absorbed dose and bone marrow toxicity for 186Re-HEDP treatment of skeletal metastases from prostate cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/12761596

Download in:

View as

General Info

PMID
12761596